Zhuhai Trinomab Pharmaceutical Co. Ltd. A (688806) Stock Price & News

All values in CNY	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Revenue	169.32K	10.37M	24.93M	51.31M
Cost of goods sold	5.91M	558.86K	14.82M	10.61M
Cost of revenue	5.91M	558.86K	14.82M	10.61M
Research and development expenses	134.32M	46.89M	39.25M	50.29M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	42.63M	73.77M	66.52M	84.64M
Operating expense	176.88M	112.18M	104.70M	128.14M
Total operating expenses	182.78M	112.74M	119.53M	138.75M
Operating income	-182.61M	-102.37M	-94.60M	-87.43M
Other non operating income	-35.74K	-502.89K	-44.26K	-1.58M
EBT including unusual items	-176.72M	-113.41M	-96.50M	-103.64M
EBT excluding unusual items	-185.70M	-97.71M	-100.18M	-92.73M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-84.40K	-8.84M	-210.04K	-5.97M
Net income	-176.72M	-113.41M	-96.38M	-102.97M
Net profit margin	-104,373.22%	-1,093.65%	-386.64%	-200.67%
Earnings per share	-	-	-	-
Interest and investment income	1.39M	10.24M	884.56K	1.28M
Interest expense	-4.38M	-5.14M	-5.74M	-5.69M
Net interest expenses	-2.99M	5.10M	-4.85M	-4.41M
Depreciation and amortization charges	-	-	-	-
EBITDA	-165.12M	-95.96M	-81.23M	-87.39M
Gain or loss from assets sale	-	-263.50K	-	-51.78K

Finance